AMICUS SA
Amicus is dedicated to service of research-based pharmaceutical and healthcare companies who choose to enter the Balkans and the Baltics in partnership, and not entirely with their own subsidiaries. The company is staffed by a unique group of skilled managers and medical professionals who are dedicated to bring modern medicines to the people of our two regions. We are a service-oriented, high quality and ethically-driven company.
AMICUS SA
Industry:
Medical Pharmaceutical
Founded:
2013-01-01
Address:
Baar, Zug, Switzerland
Country:
Switzerland
Website Url:
http://www.amicuspharma.eu
Total Employee:
101+
Status:
Closed
Email Addresses:
[email protected]
Total Funding:
20 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Content Delivery Network Font Awesome Domain Not Resolving Apache JsDelivr BootstrapCDN Pound Sterling
Current Employees Featured
Founder
Investors List
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Venture Round - AMICUS SA
Official Site Inspections
http://www.amicuspharma.eu Semrush global rank: 9.59 M Semrush visits lastest month: 135
- Host name: ip64.ip-198-50-252.net
- IP address: 198.50.252.64
- Location: Australia
- Latitude: -33.494
- Longitude: 143.2104
- Timezone: Australia/Sydney
More informations about "AMICUS SA"
AMICUS SA - Crunchbase Company Profile & Funding
Contact Email [email protected] Amicus is dedicated to service of research-based pharmaceutical and healthcare companies who choose to enter the Balkans and the Baltics in โฆSee details»
AMICUS SRB d.o.o. - CompanyWall Business
Www.amicuspharma.eu. Vlasnik SWIXX BIOPHARMA AG(100,00%) Zastupnik Predrag Lukiฤ, Direktor Zastupnik Jean-Michel Patrick Lespinasse, prokurista Zastupnik Lidija Mitiฤ, zastupnik โฆSee details»
Amicus Therapeutics | Advancing Therapies to Treat Rare Diseases
Amicus Therapeutics) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering high-quality medicines for people living with rare โฆSee details»
AMICUS CHANGES NAME TO โSWIXX BIOPHARMA SAโ
[email protected], Tel: +372 509 2124 Quality Assurance: Dorde Dmitrasinovic, Swixx BioPharma [email protected] Tel: +386 30 220 942 Logistics: โฆSee details»
About Amicus - Amicus Therapeutics
We seek to deliver the highest quality therapies for persons living with these diseases; We support the disease communities โ and their families; We are passionate about what we do; โฆSee details»
AMICUS SA RECEIVES SUPPORT AND GROWTH CAPITAL FROM โฆ
For more information about Amicus, please visit: www.amicuspharma.eu. About HBM Healthcare HBM Healthcare Investments actively invests in the human medicine, biotechnology, medical โฆSee details»
Swixx BioPharma - Overview, News & Similar companies - ZoomInfo
Swixx BioPharma contact info: Phone number: +359 24942480 Website: www.amicuspharma.eu What does Swixx BioPharma do? Swixx BioPharma is an agent for ethical pharmaceuticals โฆSee details»
Appointment of István Langer as General Manager of Amicus โฆ
Until István joins Amicus, the Hungarian organization will continue to be led by Tomas ernik, interim General Manager. Once the responsibilities are transferred to István, Tomas will focus โฆSee details»
AMICUS, Company at 5A Neuhofstrasse, Baar, Zug - Switzerland
AMICUS is a company, located at 5A Neuhofstrasse, Baar, Zug 6340, Switzerland. They can be contacted via phone at +381 11 4426300, visit their website www.amicuspharma.eu, โฆSee details»
Amicus' Pompe approval portends a showdown with Sanofi
Mar 28, 2023 Amicus nabs EU nod for Pompe disease newcomer Pombiliti, setting up fight with Sanofi. By Fraiser Kansteiner Mar 28, 2023 10:25am. Amicus Therapeutics European โฆSee details»
Amicus Therapeutics - LinkedIn
Amicus Therapeutics | 45,270 followers on LinkedIn. Our passion for making a difference unites us. | We are a global, patient-dedicated biotechnology company focused on discovering, โฆSee details»
Union Register of medicinal products - Public health - European โฆ
Apr 7, 2024 Live, work, travel in the EU; Union Register support. Public Health - Union Register of medicinal products. General index of products by Marketing Authorisation Holders and โฆSee details»
European Medicines Agency Validates Amicus Therapeutics โฆ
PHILADELPHIA, Dec. 03, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the European Medicines Agency (EMA) validated the Marketing โฆSee details»
PERSONNEL ANNOUNCEMENT - Swixx BioPharma
[email protected], Tel: +381 11 4426 321 . Author: BMS Created Date: 10/12/2015 3:35:13 PM ...See details»
Amicus Therapeutics - Craft
Oct 29, 2024 Amicus Therapeutics has 5 employees across 11 locations and $528.3 m in annual revenue in FY 2024. See insights on Amicus Therapeutics including office locations, โฆSee details»
Development Pipeline - Amicus Therapeutics
Development Pipeline At Amicus we are business led and science driven to deliver meaningful benefits to patients. We believe that our advanced product pipeline and platform technologies โฆSee details»
AMICUS SIGNS NOVEL PAIN COMBO MAXIGESIC FOR BALTICS, โฆ
AMICUS SIGNS NOVEL PAIN COMBO MAXIGESIC โข FOR BALTICS, CENTRAL EUROPE AND WEST BALKANS PRESS RELEASE NO. 16: AMICUS AG and AFT Pharmaceuticals โฆSee details»
Amicus Therapeutics - Wikipedia
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, PA. [3] The company went public in 2007 under the NASDAQ trading symbol โฆSee details»
AMICUS AND OTSUKA SIGN DISTRIBUTION DEAL FOR JINARC®
(tolvaptan) across all of Central and Eastern European EU countries as well as two Western European countries. Baar, Switzerland, March 11th, 2019: Amicus S.A. of Baar, Switzerland โฆSee details»
AMICUS SIGNS CO-PROMOTION CONTRACTS WITH โฆ
[email protected], Tel: +381 11 4426 321. Author: BMS Created Date: 10/17/2017 7:34:45 PM ...See details»